Gary Ingenito - 09 Aug 2024 Form 4 Insider Report for CATALYST PHARMACEUTICALS, INC. (CPRX)

Role
Chief Med. & Reg. Officer
Signature
/s/ Gary Ingenito
Issuer symbol
CPRX
Transactions as of
09 Aug 2024
Net transactions value
-$1,403,000
Form type
4
Filing time
13 Aug 2024, 17:01:01 UTC
Previous filing
07 Jun 2024
Next filing
22 Nov 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CPRX Common stock, par value $0.001 per share Options Exercise $401,000 +100,000 +195% $4.01 151,391 09 Aug 2024 Direct
transaction CPRX Common stock, par value $0.001 per share Sale $1,804,000 -100,000 -66% $18.04 51,391 09 Aug 2024 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CPRX Options to purchase common stock Options Exercise $0 -100,000 -9.5% $0.000000 950,575 09 Aug 2024 Common Stock 100,000 $4.01 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares were sold on the open market for personal reasons and not as a result of any disagreement with the Company.
F2 Represents a weighted average price for the shares sold. Shares were sold in various lots ranging from $17.58 to $18.25 per share.
F3 Options vested in three annual tranches beginning on January 2, 2019.